Peplin
Peplin officials summarized the newest activities
Published in Health Business Week, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Peplin.
Report 1: Peplin Limited (PEP) has initiated proceedings to secure its tenancy of the J. H. Aylward manufacturing facility in Southport, Queensland.
The manufacturing facility is Peplin's recently commissioned and licensed facility for the production of PEP005, the active ingredient in PEP005 Topical, its proprietary product being developed for the treatment of actinic (solar) keratosis and basal cell carcinoma, the most common form of skin cancer. The facility was opened...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-01-19)
More Articles from Health Business Week
- Adverse Drug Reaction
Bayer informs healthcare professionals of safety revisions to the Trasylol label - Alzheimer Disease
Dosing commenced in Phase IIa trial of PBT2 in early Alzheimer patients - Anemia
Roche submits added data to U.S. FDA to support license application for anti-anemia agent - Anthrax Vaccine
U.S. Health & Human Services cancels VaxGen's anthrax vaccine contract - Antibacterial Agents
New Drug Application submitted for investigational antibiotic Doripenem - Asthma
Half of newly diagnosed asthmatics do not fill prescriptions within a year of diagnosis - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
